VCM
RDY icon

Versant Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Versant Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.93K Buy
340
+113
+50% +$1.52K ﹤0.01% 2435
2026
Q1 		$3.14K Buy
+227
New +$3.16K ﹤0.01% 2484

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Versant Capital Management's RDY Position: Q2 2026 in Review

Versant Capital Management increased its Dr. Reddy's Laboratories (RDY) stake by 50% in Q2 2026, buying an estimated $1.52K and bringing the position to 340 shares worth $4.93K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.

Versant Capital Management first reported a position in RDY in Q1 2026 and has held it in 2 quarters since. 42 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Versant Capital Management held 340 shares of Dr. Reddy's Laboratories worth $4.93K as of Q2 2026.
  • Versant Capital Management bought 113 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $1.52K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2435 holding.
  • Versant Capital Management first reported a position in Dr. Reddy's Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 42 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.